The GP Show

Professor George Jelinek is Professor and Founder of the Neuroepidemiology Unit (NEU) within the Melbourne School of Population and Global Health at The University of Melbourne.  The NEU’s charter is to investigate the modifiable lifestyle risk factors that predict the progression of MS with a view to refining a preventive medicine approach to management of the disease.

Professor Jane Burns is Professor of Innovation and Industry at the University of Sydney. In 2010 she raised $35 million as the founder and CEO of Young and Well CooperativeResearchCentre an organisation that over its five years drove industry focused research and development to explore the role of new and emerging technology in improving wellbeing. She has a PhD in Medicine from the Faculty of Medicine (Public Health and Epidemiology) University of Adelaide. She was the 2015 Winner, Social Enterprise and Not-For-Profit Award Category, Inaugural Westpac/Financial Review 100 Women of Influence.

She has a special interest in disability care, veterans and mental health and how innovative technologies can be integrated into healthcare. We have a brief yarn discussing online platforms, apps, avatars, biometric devices, virtual reality, AI, personalised medicine implications. There was so much more to cover but this may stimulate your creative thinking in this space!

Some of the mention platforms:

https://headtohealth.gov.au/

https://highres.dva.gov.au/highres/#!/home

https://www.patientslikeme.com/

https://au.reachout.com/

http://www.c25k.com/

Professor Burns conflicts of interest include:

Chair of VVCS, chair of soldierly and CEO of emotion21

Enjoy Friends

Professor Jane Burns is Professor of Innovation and Industry at the University of Sydney. In 2010 she raised $35 million as the founder and CEO of Young and Well CooperativeResearchCentre an organisation that explores the role of new and emerging technology in improving wellbeing.  She has a PhD in Medicine (Public Health and Epidemiology). She was the 2015 Winner at the Financial Review 100 Women of Influence.

She has a special interest in disability care, veterans and mental health.

Professor Susan Davis is a National Health and Medical Research Council of Australia Senior Principal Research Fellow, Professor of Women's Health in the School of Public Health and Preventive Medicine, Monash University, Consultant Endocrinologist, President of the International Menopause Society, co-founder of the Jean Hailes Foundation and past President of the Australasian Menopause Society. Just to name a few!

We discuss:

1. Initiating hormone replacement therapy (HRT)
2. Risks and benefits
3. Ceasing HRT
4. Testosterone for women? Evidence, indications, pros/cons
5. Bioidentical HRT - what is it? evidence, pros, cons
6. Tailored HRT - to bloods/salvia results - evidence? pros/cons?
7. Good resources

Professor Davis declared conflicts of interest include:

Received honoraria from Besins Healthcare, Pfizer and Lawley pharmaceuticals Consultant to Que Oncology and Mayne Pharmaceuticals Enjoy friends

Professor Susan Davis is a National Health and Medical Research Council of Australia Senior Principal Research Fellow, Professor of Women's Health in the School of Public Health and Preventive Medicine, Monash University, Consultant Endocrinologist, President of the International Menopause Society, co-founder of the Jean Hailes Foundation and past President of the Australasian Menopause Society.  Just to name a few!

A/Professor Grant is a Biochemical Pharmacologist in the School of Medical Sciences University of NSW, Clinical Associate Professor at the Sydney Adventist Hospital Clinical School, University of Sydney and Head of the Australasian Research Institute.

A/Professor Grant's research focusses on characterizing, at the molecular level, how lifestyle and environment (e.g. emotional stress, diet and exercise) produce changes in the body's biochemistry that lead toward either health or disease; including oxidative stress, inflammation and changes in metabolism. A practical goal of this research is identification of early subclinical disease (often linked to accelerated aging) enabling effective intervention before irreparable damage to tissue occurs.

A/Professor Grant had no COI to declare.

Interested in Lifestyle Medicine? Check out the Australasian Society of Lifestyle Medicine @ http://lifestylemedicine.org.au/

Enjoy Friends

A/Professor Grant is a Biochemical Pharmacologist in the School of Medical Sciences University of NSW, Clinical Associate Professor at the Sydney Adventist Hospital Clinical School, University of Sydney and Head of the Australasian Research Institute.

Dr Pamela Douglas MBBS FRACGP IBCLC PhD is the Medical Director @ Possums Education, www.possumsonline.com, Adjunct Associate Professor of Maternity Newborn and Families Research Collaborative MHIQ @ Griffith University and Senior Lecturer in the Discipline of General Practice @ The University of Queensland. www.pameladouglas.com.au

Today we discuss the concepts of neuroprotective developmental care, the Possums programs for clinicians and parents and the 5 domains of approaching an unsettled infant.

We had lots of technical glitches (cats, dogs, birds, internet etc), just one of those days, but Pamela is as lovely as she is smart, so despite those interruptions - it went well!

Enjoy friends

Dr Pamela Douglas MBBS FRACGP IBCLC PhD is the Medical Director @ Possums Education, www.possumsonline.com, Adjunct Associate Professor of Maternity Newborn and Families Research Collaborative MHIQ @ Griffith University and Senior Lecturer in the Discipline of General Practice @ The University of Queensland.

Today we discuss the concepts of neuroprotective developmental care, the Possums programs for clinicians and parents and the 5 domains of approaching an unsettled infant.

Professor Helena Teede MBBS, PhD, FRACP, FAAHMS is an Endocrinologist at Monash Health, Professor of women's health at Monash Public Health and Medicine, Monash University and the Lead Author of the 2018 "Evidence-based Guideline for the assessment and management of polycystic ovary syndrome (PCOS)". She is also Director at the National Health and Medical Research Council Centre of Excellence in PCOS, Director at the Monash Centre for Health Research and Implementation (MCHRI) and Executive Director at the Monash Partners Academic Health Sciences Centre.

Today we review the latest 2018 PCOS guidelines discussing; prevalence, cause, pathophysiology, diagnostic criteria, other associated symptoms, lifestyle interventions, pharmaceutical treatments, fertility treatments, potential supplements and future treatments and resources for patients and health professionals.

A few minor technical glitches due to recording volume, my apologies.

Enjoy friends